Genetics of postoperative complications following thoracic surgery

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 4, 2006, Pages 327-345

  Shaw, Andrew ^a,b  

^a Division of Cardiothoracic Anesthesiology and Critical Care Medicine   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetic traits; Postoperative complications; Thoracic surgery

Indexed keywords

INTERLEUKIN 6; TOLL LIKE RECEPTOR 4;

GENE INTERACTION; GENETIC ANALYSIS; HUMAN; METHODOLOGY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; THORACOTOMY; THORAX SURGERY;

ARRHYTHMIA; GENOTYPE; HUMANS; LUNG DISEASES; MODELS, GENETIC; PROBABILITY; RISK FACTORS; THORACIC SURGICAL PROCEDURES; VARIATION (GENETICS);

EID: 33750686635     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253206294368     Document Type: Review

References (156)

1. Graham E, Singer J. Successful removal of an entire lung for carcinoma of the bronchus. JAMA. 1933;101:1371-1374.
2. Vaporciyan AA, Merriman KW, Ece F, et al. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg. 2002;73:420-425; discussion 5-6.
3. Walsh GL, Morice RC, Putnam JB, Jr. et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg. 1994;58:704-710; discussion 11.
4. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126-1132.
5. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236:376-384; discussion 84-85.
6. Wahi R, McMurtrey MJ, DeCaro LF, et al. Determinants of perioperative morbidity and mortality after pneumonectomy. Ann Thorac Surg. 1989;48:33-37.
7. Wilkins EW, Jr., Scannell JG, Craver JG. Four decades of experience with resections for bronchogenic carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg. 1978;76:364-368.
8. Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988;96:894-900.
9. Ferguson MK, Reeder LB, Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995;109:275-281; discussion 81-3.
10. Komaki R, Roth JA, Walsh GL, et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 2000;48:347-354.
11. Jagoe RT, Goodship TH, Gibson GJ. The influence of nutritional status on complications after operations for lung cancer. Ann Thorac Surg. 2001;71:936-943.
12. Wu X, Schabath MB, Spitz MR. Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med. 2003;75:121-133.
13. Spitz MR, Barnett MJ, Goodman GE, et al. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002;11:1413-1418.
14. Jones KG, Brull DJ, Brown EC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 2001;103:2260-2265.
15. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166:646-650.
16. Humphries SE, Luong EA, Ogg MS, et al. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 2001;22:2243-2252.
17. Cykert S, Kissling G, Hansen CJ. Patient preferences regarding possible outcomes of lung resection: what outcomes should preoperative evaluations target? Chest 2000;117:1551-1559.
18. Boyd O. Case-mix adjustment and prediction of mortality-the problems with interpretation. In: Ridley S, ed. Outcomes in Critical Care. Oxford: Butterworth-Heinemann, 2002:83-103.
19. Harpole DH, Liptay MJ, DeCamp MM, Jr., et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996;61:977-982.
20. Ploeg AJ, Kappetein AP, van Tongeren RB et al. Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung. Eur J Cardiothorac Surg. 2003;23:26-29.
21. Licker M, de Perrot M, Hohn L et al. Perioperative mortality and major cardio-pulmonary complications after lung surgery for non-small cell carcinoma. Eur J Cardiothorac Surg. 1999;15:314-319.
22. Wang J, Olak J, Ultmann RE, Ferguson MK. Assessment of pulmonary complications after lung resection. Ann Thorac Surg. 1999;67:1444-1447.
23. Ruffini E, Parola A, Papalia E, et al. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma. Eur J Cardiothorac Surg. 2001;20:30-36, discussion 6-7.
24. Kutlu CA, Williams EA, Evans TW, et al. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg. 2000;69:376-380.
25. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
26. Higgins GA, Beebe GW. Bronchogenic carcinoma. Factors in survival. Arch Surg. 1967;94:539-549.
27. Van Nostrand D, Kjelsberg MO, Humphrey EW. Preresectional evaluation of risk from pneumonectomy. Surg Gynecol Obstet. 1968;127:306-312.
28. Reichel J. Assessment of operative risk of pneumonectomy. Chest 1972;62:570-6.
29. Olsen GN, Block AJ, Swenson EW et al. Pulmonary function evaluation of the lung resection candidate: a prospective study. Am Rev Respir Dis. 1975;111:379-387.
30. Harmon H, Fergus S, Cole FH. Pneumonectomy: review of 351 cases. Ann Surg. 1976;183:719-722.
31. Boysen PG, Block AJ, Olsen GN et al. Prospective evaluation for pneumonectomy using the 99mtechnetium quantitative perfusion lung scan. Chest. 1977;72:422-425.
32. Keagy BA, Schorlemmer GR, Murray GF, et al. Correlation of preoperative pulmonary function testing with clinical course in patients after pneumonectomy. Ann Thorac Surg. 1983;36:253-257.
33. Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;86:654-8.
34. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139:902-910.
35. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest. 1992;101:1332-1337.
36. Patel RL, Townsend ER, Fountain SW. Elective pneumonectomy: factors associated with morbidity and operative mortality. Ann Thorac Surg. 1992;54:84-88.
37. Miller JI, Jr. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg. 1993;105:347-351; discussion 51-2.
38. Conlan AA, Lukanich JM, Shutz J, Hurwitz SS. Elective pneumonectomy for benign lung disease: modern-day mortality and morbidity. J Thorac Cardiovasc Surg. 1995;110:1118-1124.
39. Mitsudomi T, Mizoue T, Yoshimatsu T, et al. Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis. J Surg Oncol. 1996;61:218-222.
40. Cerfolio RJ, Allen MS, Trastek VF, et al. Lung resection in patients with compromised pulmonary function. Ann Thorac Surg. 1996;62:348-351.
41. Prause G, Offner A, Ratzenhofer-Komenda B, et al. Comparison of two preoperative indices to predict perioperative mortality in non-cardiac thoracic surgery. Eur J Cardiothorac Surg. 1997;11:670-675.
42. Melendez JA, Carlon VA. Cardiopulmonary risk index does not predict complications after thoracic surgery. Chest. 1998;114:69-75.
43. Naunheim KS, Kaiser LR, Bavaria JE, et al. Long-term survival after thoracoscopic lung volume reduction: a multiinstitutional review. Ann Thorac Surg. 1999;68:2026-2031; discussion 31-32.
44. Bernard A, Ferrand L, Hagry O, et al. Identification of prognostic factors determining risk groups for lung resection. Ann Thorac Surg. 2000;70:1161-1167.
45. Blyth DF. Pneumonectomy for inflammatory lung disease. Eur J Cardiothorac Surg. 2000;18:429-434.
46. Stephan F, Boucheseiche S, Hollande J, et al. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest. 2000;118:1263-1270.
47. Wang JS, Abboud RT, Evans KG, et al. Role of CO diffusing capacity during exercise in the preoperative evaluation for lung resection. Am J Respir Crit Care Med. 2000;162:1435-1444.
48. Bernard A, Deschamps C, Allen MS, et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg. 2001;121:1076-1082.
49. Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management. J Am Coll Surg. 2002;194:285-297.
50. Doty JR, Salazar JD, Forastiere AA, et al. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg. 2002;74:227-231; discussion 31.
51. Brunelli A, Al Refai M, Monteverde M, et al. Stair climbing test predicts cardiopulmonary complications after lung resection. Chest. 2002;121:1106-1110.
52. Licker M, Spiliopoulos A, Frey JG, et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest. 2002;121:1890-1897.
53. Ferguson MK, Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg. 2003;23:35-42.
54. Algar FJ, Alvarez A, Salvatierra A, et al. Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg. 2003;23:201-208.
55. Licker M, Spiliopoulos A, Frey JG, et al. Management and outcome of patients undergoing thoracic surgery in a regional chest medical centre. Eur J Anaesthesiol. 2001;18:540-547.
56. Sadeghi N, Sadeghi S, Mood ZA, Karimi A. Determinants of operative mortality following primary coronary artery bypass surgery. Eur J Cardiothorac Surg. 2002;21:187-192.
57. Deschamps C, Bernard A, Nichols FC, 3rd, et al. Empyema and bronchopleural fistula after pneumonectomy: factors affecting incidence. Ann Thorac Surg. 2001;72:243-247; discussion 248.
58. Myrdal G, Gustafsson G, Lambe M, et al. Outcome after lung cancer surgery. Factors predicting early mortality and major morbidity. Eur J Cardiothorac Surg. 2001;20:694-699.
59. Miller DL, Deschamps C, Jenkins GD, et al. Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity. Ann Thorac Surg. 2002;74:876-883; discussion 83-84.
60. Muysoms FE, de la Riviere AB, Defauw JJ, et al. Completion pneumonectomy: analysis of operative mortality and survival. Ann Thorac Surg. 1998;66:1165-1169.
61. Kohman LJ, Meyer JA, Ikins PM, Oates RP. Random versus predictable risks of mortality after thoracotomy for lung cancer. J Thorac Cardiovasc Surg. 1986;91:551-554.
62. Whittle J, Steinberg EP, Anderson GF, Herbert R. Use of Medicare claims data to evaluate outcomes in elderly patients undergoing lung resection for lung cancer. Chest. 1991;100:729-734.
63. Yano T, Yokoyama H, Fukuyama Y, et al. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg. 1997;11:445-449.
64. Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: a prospective, multicenter study. Grupo Cooperativo de Carcinoma Broncogenico de la Sociedad Espanola de Neumologia y Cirugia Toracica. Ann Thorac Surg. 1997;63:944-950.
65. Handy JR, Jr., Child AI, Grunkemeier GL, et al. Hospital readmission after pulmonary resection: prevalence, patterns, and predisposing characteristics. Ann Thorac Surg. 2001;72:1855-1859; discussion 1859-1860.
66. Deslauriers J, Ginsberg RJ, Dubois P, et al. Current operative morbidity associated with elective surgical resection for lung cancer. Can J Surg. 1989;32:335-339.
67. Wada H, Nakamura T, Nakamoto K, et al. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg. 1998;115:70-73.
68. Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J. 1996;9:7-10.
69. Naunheim KS, Hazelrigg SR, Kaiser LR, et al. Risk analysis for thoracoscopic lung volume reduction: a multi-institutional experience. Eur J Cardiothorac Surg. 2000;17:673-679.
70. Deslauriers J, Ginsberg RJ, Piantadosi S, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest. 1994;106:329S-330S.
71. Alexiou C, Beggs D, Rogers ML, et al. Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival. Eur J Cardiothorac Surg. 2001;20:476-480.
72. Pierce RJ, Copland JM, Sharpe K, Barter CE. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med. 1994;150:947-955.
73. Keagy BA, Lores ME, Starek PJ, et al. Elective pulmonary lobectomy: factors associated with morbidity and operative mortality. Ann Thorac Surg. 1985;40:349-352.
74. Alexiou C, Onyeaka CV, Beggs D, et al. Do women live longer following lung resection for carcinoma? Eur J Cardiothorac Surg. 2002;21:319-325.
75. Forster R, Toth S, Redmann K, et al. A prospective risk analysis of contemporary thoracic surgery. Eur J Cardiothorac Surg. 1996;10:641-648.
76. Gebitekin C, Martin PG, Satur CM, et al. Results of pneumonectomy for cancer in patients with limited ventilatory function. Eur J Cardiothorac Surg. 1995;9:347-351.
77. Putnam JB, Jr, Lammermeier DE, Colon R, et al. Predicted pulmonary function and survival after pneumonectomy for primary lung carcinoma. Ann Thorac Surg. 1990;49:909-914; discussion 915.
78. Algar FJ, Alvarez A, Aranda JL, et al. Prediction of early bronchopleural fistula after pneumonectomy: a multivariate analysis. Ann Thorac Surg. 2001;72:1662-1667.
79. Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 1994;105:753-759.
80. Melendez JA, Barrera R. Predictive respiratory complication quotient predicts pulmonary complications in thoracic surgical patients. Ann Thorac Surg. 1998;66:220-224.
81. Filaire M, Bedu M, Naamee A, et al. Prediction of hypoxemia and mechanical ventilation after lung resection for cancer. Ann Thorac Surg. 1999;67:1460-1465.
82. Bonde P, McManus K, McAnespie M, McGuigan J. Lung surgery: identifying the subgroup at risk for sputum retention. Eur J Cardiothorac Surg. 2002;22:18-22.
83. Uramoto H, Nakanishi R, Fujino Y, et al. Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer. Thorax. 2001;56:59-61.
84. Hubaut JJ, Baron O, Al Habash O, et al. Closure of the bronchial stump by manual suture and incidence of bronchopleural fistula in a series of 209 pneumonectomies for lung cancer. Eur J Cardiothorac Surg. 1999;16:418-423.
85. Busch E, Verazin G, Antkowiak JG, et al. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest. 1994;105:760-766.
86. Rea F, Loy M, Bortolotti L, et al. Morbidity, mortality, and survival after bronchoplastic procedures for lung cancer. Eur J Cardiothorac Surg. 1997;11:201-205.
87. Bousamra M, 2nd, Presberg KW, Chammas JH, et al. Early and late morbidity in patients undergoing pulmonary resection with low diffusion capacity. Ann Thorac Surg. 1996;62:968-974; discussion 974-975.
88. Wang J, Olak J, Ferguson MK. Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg. 1999;117:581-586; discussion 586-587.
89. Shiraishi Y, Nakajima Y, Koyama A, et al. Morbidity and mortality after 94 extrapleural pneumonectomies for empyema. Ann Thorac Surg. 2000;70:1202-1206; discussion 1206-1207.
90. van der Werff YD, van der Houwen HK, Heijmans PJ, et al. Postpneumonectomy pulmonary edema. A retrospective analysis of incidence and possible risk factors. Chest. 1997;111:1278-1284.
91. Brunelli A, Monteverde M, Salati M, et al. Stair-climbing test to evaluate maximum aerobic capacity early after lung resection. Ann Thorac Surg. 2001;72:1705-1710.
92. Ninan M, Sommers KE, Landreneau RJ, et al. Standardized exercise oximetry predicts postpneumonectomy outcome. Ann Thorac Surg. 1997;64:328-332; discussion 32-33.
93. Varela G, Cordovilla R, Jimenez MF, Novoa N. Utility of standardized exercise oximetry to predict cardiopulmonary morbidity after lung resection. Eur J Cardiothorac Surg. 2001;19:351-354.
94. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
95. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082-1088.
96. Van Den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
97. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301-1308.
98. Pinsky MR. Toward a better ventilation strategy for patients with acute lung injury. Crit Care. 2000;4:205-206.
99. Meyer S. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281-285.
100. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845-850.
101. Brunelli A, Fianchini A, Gesuita R, Carle F. POSSUM scoring system as an instrument of audit in lung resection surgery. Physiological and operative severity score for the enumeration of mortality and morbidity. Ann Thorac Surg. 1999;67:329-331.
102. Copeland GP, Jones D, Walters M. POSSUM: a scoring system for surgical audit. Br J Surg. 1991;78:355-360.
103. Epstein SK, Faling LJ, Daly BD, Celli BR. Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest 1993;104:694-700.
104. Esteva H, Marchevsky A, Nunez T, et al. Neural networks as a prognostic tool of surgical risk in lung resections. Ann Thorac Surg. 2002;73:1576-1581.
105. Donahue BS, Byrne DW, Gailani D, George AL, Jr. Tissue factor and platelet glycoprotein Ib-alpha alleles are associated with age at first coronary bypass operation. Anesthesiology. 2003;99:1287-1294.
106. Gaudino M, Andreotti F, Zamparelli R, et al. The - 174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation. 2003;108:II195-II199.
107. Gaudino M, Di Castelnuovo A, Zamparelli R, et al. Genetic control of postoperative systemic inflammatory reaction and pulmonary and renal complications after coronary artery surgery. J Thorac Cardiovasc Surg. 2003;126:1107-1112.
108. Shaw AD, Vaporciyan AA, Wu X, et al. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg. 2005;79:1704-1710.
109. Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J. 1972;34:520-525.
110. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.
111. Sata N, Hamada N, Horinouchi T, et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J. 2004;45:441-445.
112. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
113. Natanson C, Eichenholz PW, Danner RL, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med. 1989;169:823-832.
114. Eichenholz PW, Eichacker PQ, Hoffman WD, et al. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol. 1992;263:H668-H675.
115. Seguin P, Signouret T, Laviolle B, et al. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med. 2004;32:722-726.
116. Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol. 2004;93:1176-1178.
117. Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96:3542-3548.
118. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005;26:2083-2092.
119. Meduri GU, Yates CR. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS. Ann N Y Acad Sci. 2004;1024:24-53.
120. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1037-1050.
121. Meduri GU, Kohler G, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995;108:1303-1314.
122. Martin TR. Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance. Nat Med. 1997;3:272-273.
123. Papadakos PJ. Cytokines, genes, and ARDS. Chest. 2002;121:1391-1392.
124. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995;75:257-277.
125. Kucukaydin M, Kocaoglu C, Koksal F, Kontas O. Detection of intestinal bacterial translocation in subclinical ischemia-reperfusion using the polymerase chain reaction technique. J Pediatr Surg. 2000;35:41-43.
126. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992;18:20-25.
127. Tashiro T, Yamamori H, Takagi K, et al. Changes in immune function following surgery for esophageal carcinoma. Nutrition 1999;15:760-766.
128. Marshall RP, Webb S, Bellingan GJ, et al. Genetic polymorphisms in the Interleukin-1 complex and survival in ARDS. Am J Respir Crit Care Med. 2003;167:A161.
129. Donahue BS, Balser JR. Perioperative genomics. Venturing into uncharted seas. Anesthesiology. 2003;99:7-8.
130. Vachani A, Christie JD, Aplenc R, et al. The prevalence of polymorphisms in reactive oxygen species (ROS) regulation genes in patients iwth major trauma. Am J Respir Crit Care Med. 2003;167:A161.
131. Sutherland A, Manocha S, Walley KR, Russell JA. C159T CD14 polymorphism is associated with increased infection in critically ill adults. Am J Respir Crit Care Med. 2003;167:A162.
132. French JK, Van de Water NS, Sutton TM, et al. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. Am Heart J. 2003;145:118-124.
133. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195.
134. Nizankowska-Mogilnicka E, Adamek L, Grzanka P, et al. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J. 2003;21:25-30.
135. Jones K, Powell J, Brown L, et al. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2002;23:421-425.
136. Garcia-Otin AL, Civeira F, Aristegui R, et al. Allelic polymorphism -491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment. Eur J Clin Invest. 2002;32:421-428.
137. Cipollone F, Patrono C. Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? Arterioscler Thromb Vasc Biol. 2002;22:1516-1518.
138. Percy MJ, McMullin MF, Lappin TR. Sequence analysis of the 3′ hypoxia-responsive element of the human erythropoietin gene in patients with erythrocytosis. Biochem Mol Med. 1997;62:132-134.
139. Templeton AR, Clark AG, Weiss KM, et al. Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet. 2000;66:69-83.
140. Reich DE, Cargill M, Bolk S, et al. Linkage disequilibrium in the human genome. Nature. 2001;411:199-204.
141. Bray MS, Boerwinkle E, Doris PA. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat. 2001;17:296-304.
142. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45-61.
143. Stafford-Smith M, Podgoreanu M, Swaminathan M, et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis. 2005;45:519-530.
144. Grocott HP, White WD, Morris RW, et al. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke. 2005;36:1854-1858.
145. Newton-Cheh C, Hirschhorn JN. Genetic association studies of complex traits: design and analysis issues. Mutat Res. 2005;573:54-69.
146. Lake SL, Lyon H, Tantisira K, et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered. 2003;55:56-65.
147. Schaid DJ. Evaluating associations of haplotypes with traits. Genet Epidemiol. 2004;27:348-364.
148. Marchini J, Donnelly P, Cardon LR. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet. 2005;37:413-417.
149. Breiman L. Classification and Regression Trees. New York: Kluwer Academic Publishers, 1984.
150. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598-604.
151. Devlin B, Roeder K. Genomic control for association studies. Biometrics. 1999;55:997-1004.
152. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 1955;11:375-386.
153. Bacanu SA, Devlin B, Roeder K. The power of genomic control. Am J Hum Genet. 2000;66:1933-1944.
154. Morton NE, Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci U S A. 1998;95:11389-11393.
155. Gordon D, Finch SJ, Nothnagel M, Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered. 2002;54:22-33.
156. Edwards BJ, Haynes C, Levenstien MA, et al. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies. BMC Genet. 2005;6:18.